Saline Breast Implants Areola Incision in CA
Saline Breast Implants Areola Incision in CA section, includes general infrmation about Saline Breast Implants Areola Incision Procedure, Saline Breast Implants Areola Incision CA Local News, Saline Breast Implants Areola Incision CA Surgeon Locator and other Saline Breast Implants Areola Incision related material.
Saline Breast Implants Areola Incision Procedure
Breast augmentation, or augmentation mammoplasty, is one of the most common plastic surgery procedure performed today. Over time, factors such as age, genetics, pregnancy, weight changes, sun exposure, and gravity can cause the size and shape of the breast to change. Women who are dissatisfied with the size of their breasts, or have experienced changes in breast appearance can achieve a fuller, shapelier breast with breast augmentation. During breast augmentation, a breast implant is placed inside a pocket formed in the breast tissue. This can help to increase or balance the size of the breast, restore breast volume, or restore the shape of the breast after partial or total loss. It is important to realize that breast augmentation cannot correct significantly sagging or drooping breasts. In these instances, a breast lift is often necessary, which may be performed in conjunction with this procedure.
Saline implants are made of a silicone rubber shell and are filled with sterile saline solution, or salt water. Sterile saline solution has the same salt concentration as the body, which means that the solution presents very little health risk. You must be at least 18 years of age to receive saline implants. Breast implants differ by shape, texture, and profile. Breast implants may be round or contoured, and may have a smooth or textured surface. The breast implant profile may be standard, moderate, or high. Lastly, breast implants vary by size, or volume. The type, style, and size of breast implants you choose are determined by your lifestyle, body contours, the amount of breast tissue you have, and the cup size and appearance that you would like to achieve. Be sure to talk with your doctor in depth about choosing the breast implant option that is right for you.
The breast consists of glands and milk ducts, surrounded by fatty tissue which provides its shape and soft form. The elasticity of your skin also contributes to its shape. As you know, certain factors such as age and pregnancy can affect the elasticity of your skin and breast tissue, which results in changes to shape and appearance.
Breast implants can be placed in two general locations, known as submuscular and subglandular placement. Submuscular placement refers to an implant that is placed partially or completely beneath the pectoralis muscle, against the chest wall. In contrast, subglandular placement refers to an implant that is placed beneath the breast tissue, but above the pectoralis muscle. Your surgeon will help determine the implant placement that is best for you.
Breast augmentation procedures typically last approximately one to two hours. Prior to the start of your procedure the treatment area will be thoroughly cleansed and an anesthetic will be administered. Depending on the surgeon’s preferences and the nature of the procedure, a local anesthetic in combination with intravenous sedation or general anesthesia will be used.
The periareolar incision is one of the most common incisions used in breast augmentation. A single small incision is usually placed along the perimeter of the areola. Using an instrument known as a retractor, the surgeon will open the incision in order to gain better access to the breast tissue below. Although the incision will be made as inconspicuously as possible, its length and appearance may vary depending on the type and size of implant, your body contours, and the surgeon’s preference.
The surgeon will carefully separate the breast tissue with a minimally invasive cautery device and a scalpel, in order to reach the area of the breast in which the pocket will be formed. Using an instrument known as an elevator and their fingers, the surgeon will carefully create a pocket in which to place the breast implant.
Most saline implants are filled during surgery. Therefore, saline implants are usually inserted into the breast empty. A tube attached to a valve on the breast implant allows the surgeon to fill the implant. Once the implant is inserted into the pocket, the surgeon will use a syringe to fill the implant with sterile saline solution. When the implants are filled, your surgeon will visually inspect your breasts to ensure that they are symmetric. They may add additional saline solution to one or both breast implants, adjust the pocket, and the position of the breast implant itself to ensure that the desired look is achieved. Once satisfied, the surgeon will remove the tube used to deliver the saline solution, sealing the implants.
The incisions will be closed using sutures in the breast tissue. Sutures, skin adhesive or surgical tape may be used to close the skin. Your surgeon may choose to use non-dissolving sutures, which will be removed in seven to ten days. The scars from the incisions will fade slowly over several months, but it may take up to a year for them to refine completely. As with any surgery, you will most likely experience some pain and swelling after surgery. The majority of the swelling will likely subside within a few days. However, some swelling may persist for several weeks.
Your physician may place you in a special bra or compression garment to aid in the healing process. Compression garments provide support and comfort, minimize swelling, and help to maintain the position of the implants. This is why it is important that you wear the compression garment as recommended by your physician.
You will most likely be able to return to work within three to seven days after your procedure. However, it is important that you avoid any strenuous activity and lifting for approximately three to four weeks. Doing so may delay healing and could damage the implants. You will be able to notice the final results from your procedure once the implants have settled and the swelling has subsided completely.
It is important to realize that your breasts will continue to change shape over time. However, the results from breast augmentation are typically long-lasting, which means that your breasts will maintain the fuller, shapelier appearance that you desire for years to come.
Other Saline Breast Implants Areola Incision Procedures
All Breast Procedures
Saline Breast Implants Areola Incision CA (current)
Saline Breast Implants Areola Incision CA Breast Lift
Saline Breast Implants Areola Incision CA Breast Implants
Saline Breast Implants Areola Incision CA Implant Removal
Saline Breast Implants Areola Incision CA Armpit Incision
More CA info...
Canada Time zones The Canadian Sir Sandford Fleming first proposed time zones for the entire world in 1876, and Canada is covered coast to coast with multiple zones.
Canada Understand Canada is a land of vast distances and rich natural beauty. Economically and technologically, it resembles its neighbour to the South, the United States, and shares with it the longest undefended border in the world. Canada became a self-governing dominion in 1867 by an act of British parliament, and is a member of the Commonwealth of Nations. Though a medium sized country by its population, Canada has earned respect on the international stage for its strong diplomatic skills. Internally, the country has displayed success in negotiating compromises amongst a culturally and linguistically varied population, a difficult task considering that language, culture, cuisine and even history vary significantly over the country. In contrast to the United States' image as a melting pot, Canada prefers to consider itself a mosaic of cultures and people. The information below will get you started, but be sure to check the specifics for given regions and cities. It has socialized medicine, too.
Plastic Surgery News...
- The National Institute for Health and Clinical Excellence (NICE) has published an appraisal consultation document (ACD – draft guidance) on the use of alendronate, etidronate, risedronate, raloxifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women. The guidance recommends (direct from source):
1.1 Alendronate is recommended as a treatment option for the secondary prevention of osteoporotic fragility fractures in postmenopausal women who have a T-score of -2.5 SD or below. In women aged 75 years or older, a DXA scan may not be required if the responsible clinician considers it to be clinically inappropriate or unfeasible.
When the decision has been made to initiate treatment with alendronate, the preparation prescribed should be chosen on the basis of the lowest acquisition cost available.
1.2 Risedronate and etidronate are recommended as alternative treatment options for the secondary prevention of osteoporotic fragility fractures in postmenopausal women:
• who are unable to comply with the special instructions for the administration of alendronate, have a contraindication to, or are intolerant of alendronate (as defined in section 1.7) and
• who also have a T-score, age and number of independent clinical risk factors for fracture (see section 1.5) - please refer to table in the ACD for T-scores (SD) at (or below) which risedronate or etidronate is recommended.
1.3 Raloxifene and strontium ranelate are recommended as alternative treatment options for the secondary prevention of osteoporotic fragility fractures in postmenopausal women:
• who are unable to comply with the special instructions for the administration of alendronate and risedronate, or who have a contraindication to or are intolerant of alendronate and risedronate (as defined in section 1.6) and
• who also have a T-score, age and number of independent clinical risk factors for fracture (see section 1.5) - please refer to table in the ACD for T-scores (SD) at (or below) which raloxifene or strontium ranelate is recommended.
1.4 Teriparatide is recommended as an alternative treatment option for the secondary prevention of osteoporotic fragility fractures in postmenopausal women:
• who are unable to take alendronate and risedronate, have a contraindication to, or are intolerant of alendronate and risedronate (as defined in section 1.6) or who have a contraindication to, or are intolerant of strontium ranelate (as defined in section 1.7) and
• who are 65 years or older and have an extremely low BMD (with a T-score of -4 SD or below), or a very low BMD (with a T-score of -3.5 SD or below) plus multiple fractures (that is, more than two), or who are aged 55-64 years and have a T-score of -4 SD or below plus multiple fractures (that is, more than two).
1.5 For the purposes of this guidance, independent clinical risk factors for fracture to be considered are: parental history of hip fracture, alcohol intake of 4 or more units per day, and severe, long-term rheumatoid arthritis.
1.6 For the purposes of this guidance, intolerance of alendronate and risedronate is defined as persistent upper gastrointestinal disturbance that is sufficiently severe to warrant discontinuation of treatment and that occurs even though the instructions for administration have been followed correctly.
1.7 For the purpose of this guidance, intolerance of strontium ranelate is defined as persistent nausea or diarrhoea, either of which warrants discontinuation of treatment.
1.8 Women who are currently receiving treatment with one of the drugs covered by this guidance, but for whom therapy would have not been recommended according to sections 1.1 to 1.4, should have the option to continue therapy until they and their clinicians consider it appropriate to stop.
The key dates for this appraisal are:
Closing date for comments: 23 April 2008
Second Appraisal Committee meeting: 01 May 2008
- The extraordinary results of an in utero stem cell treatment could lead to a new treatment for babies with brittle bones, as well as a range of other disabling conditions, according to a maternal-fetal medicine researcher, now based at The University of Queensland (UQ).